StockVS

NASDAQ · Medical Devices · USD

iTonic Holdings Ltd. (ITOC) Stock Analysis

iTonic Holdings Ltd. (ITOC) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

ITOC

$0.32

+$0.03 (+8.47%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare ITOC with… →

ITOC Key Statistics

As of Sep 4, 2026
Trading
Open
$0.29
Previous Close
$0.30
Day's Range
0.29–0.33
52-Week Range
0.22–1.15
Volume
250.30K
Valuation
Market Cap
$7.91M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
15.12
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.32
Financials (FY)
Revenue (FY)
$523.03K+16.70%
Net Income (FY)
−$5.10M
Profit marginThe share of revenue left as profit after all costs and taxes.
0.00%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
9.38M
1-Year Return
−68.93%
Dividend and dates
Avg Volume
1.27M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

ITOC Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−23.99%
2025−90.45%
2024 (partial year)+16.67%

As of September 4, 2026.

ITOC Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$523.03K−$5.10M−974.7%
2024$448.20K−$660.59K−147.4%
2023$628.59K−$241.22K−38.4%
2022$679.78K$83.98K12.4%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$523.03K$327.35K−$5.16M−$5.10M−974.7%
2024$448.20K$381.16K−$661.96K−$660.59K−147.4%
2023$628.59K$470.83K−$258.51K−$241.22K−38.4%
2022$679.78K$558.15K$74.53K$83.98K12.4%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

ITOC Valuation vs Medical Devices Median

Median of 151 stocks
MetricITOCMedical Devices medianvs median
P/S ratio15.122.985.1x the median
Profit margin0.00%−1.69%1.7 pts above

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values iTonic Holdings Ltd. (ITOC) at $7.91M. It is classified in the Medical Devices industry, within the Healthcare sector. The company reports 7 employees.

ITOC last closed at $0.32 on September 4, 2026. That is +$0.03 (+8.47%) against the previous close. The 52-week range on file runs from $0.22 to $1.15. The latest close sits 46.12% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $523.03K. Against the prior fiscal year total of $448.20K, that is a change of +16.70%. The same year closed with a net loss of $5.10M. Profit margin runs at 0%. That is 1.7 percentage points above the Medical Devices median of −1.69%. Earnings per share on a trailing basis come to −0.32.

Across the 4 fiscal years on file, revenue moves from $679.78K in 2022 to $523.03K in 2025. Of those 4 years, 1 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. Measured against sales, the shares trade at 15.12 times revenue. On price-to-sales that is 5.1 times the Medical Devices median of 2.98. 151 Medical Devices companies report these metrics, and the medians quoted come from that group.

Over the trailing twelve months the price has returned −68.93%. The stored price history starts on September 5, 2024, and the total return since then is −91.53%. Annualized volatility over the trailing 2 years is 168.92%.

Growth & Income

No dividend is on file for ITOC.

So far in 2026 the price is −23.99%. The record holds one complete calendar year, 2025, which returned −90.45%.

Peer Comparison

iTonic Holdings Ltd. (ITOC) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
iTonic Holdings Ltd. ITOC $7.91M
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. iTonic Holdings Ltd. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

View all Medical Devices stocks →

Popular Healthcare Stocks

View all Healthcare stocks →

About iTonic Holdings Ltd.

iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients. The company was formerly known as Pheton Holdings Ltd and changed its name to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. was founded in 1998 and is headquartered in Beijing, China. iTonic Holdings Ltd. operates as a subsidiary of ZJW (BVI) LTD.

Visit website →